SH1573 / Nanjing Sanhome Pharma 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SH1573 / Nanjing Sanhome Pharma
NCT04806659: A Phase 1 Study of SH1573 Capsules in Subjects With Refractory or Relapsed Acute Myelogenous Leukemia

Recruiting
1
41
RoW
SH1573 Capsules
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Acute Myelogenous Leukemia
08/23
12/23

Download Options